Latest news for Trident Brands (OTC:TDNT) Stock

Trident Brands Inc is a consumer product company. It is focused on the development of high growth branded and private label consumer products and ingredients within the nutritional supplement, life sciences and food and beverage categories. It offers consumer products, including nutritional products and supplements under the Everlast and Brain Armor brands. The company's brands are focused on supplements and nutritional product, and heart and brain health categories. In addition, the firm also offers various banking facilities. Geographically business activity is functioned through the region of the US and derives most of the revenue from the sale of products.

Trident Brands Inc

<ul>
<li>Ford adds a third North American assembly plant to meet Ford Pro customer demand for one of its most popular and profitable vehicles; adding initial capacity for 100,000 F-Series Super Duty trucks, including future multi-energy technology, at Oakville Assembly Complex in Ontario, Canada</li>
<li>The move supports the Ford+ plan for profitable growth, including maximizing Ford's manufacturing footprint, extending global truck leadership and expanding its Ford Pro commercial business</li>
<li>Ford will make efficient investments to expand Super Duty production, initially securing approximately 1,800 jobs at Oakville Assembly Complex and adding about 150 jobs at Windsor Engine Complex, while adding roughly 70 jobs and additional overtime at U.S. component plants</li>
<li>Ford remains committed to developing a growing and profitable electric vehicle business, including three-row electric utility vehicles, leveraging its experience as a leader in U.S. three-row utilities and America's No. 2 electric vehicle brand</li>
</ul>
Ford Motor Company today announced plans to assemble F-Series Super Duty pickups at its Oakville Assembly Complex in Ontario, Canada, starting in 2026, boosting production of one of the company's most popular and profitable vehicles.
The move to add production of up to 100,000 units of its best-selling Super Duty to Oakville expands Super Duty production across three plants in North America, including Kentucky Truck Plant and Ohio Assembly Plant, which are operating at full capacity. It also paves the way to bring multi-energy technology to the next generation of Super Duty trucks, giving customers more freedom of choice and supporting Ford's electrification plans.

News

Contracts

Global

Ford Pro Demand Drives F-Series Super Duty Production Expansion To Canada, Plans To Invest ~$3B To Expand Super Duty Production

WIIM

Novartis shares are trading lower. The company reported Q2 financial results.

Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares rose moderately in Thursday&#8217;s <a href="https://www.benzinga.com/premarket">premarket trading, </a>reversing some of the 1.57% decline seen in the previous session. 
The rebound came amid a general improvement in risk sentiment toward tech stocks after Wednesday&#8217;s drubbing. Wedbush analyst Daniel Ives, a Palantir bull, on Thursday announced a new bull-case price target of $50 for the stock. The analyst maintained an Outperform rating and a $35 price target.
Palantir has been a major focus over the past year, with expanding use cases for its marquee products leading to a large partner ecosystem, said Ives in the note. He noted that demand has been rising rapidly across both commercial and government organizations.
&#8220;With AI spending taking up more spending in IT budgets as more organizations learn how to properly implement this tech, <a href="https://www.benzinga.com/markets/equities/24/05/39104004/palantir-is-the-messi-of-artificial-intelligence-says-dan-ives-most-underestimated-ai-play">we believe the Messi of AI Palantir is in a prime spot </a>to continue expanding its pipeline as the company provides more use cases,&#8221; he said, adding that the Palantir story &#8220;remains very undervalued and misunderstood by the Street.&#8221;
Palantir is scheduled to report its second-quarter results after the market closes on Aug. 5. Analysts, on average, expect the company to report earnings of 8 cents per share, up from the year-ago&#8217;s 5 cents per share, and revenue of $652.14, representing an estimated 22.4% growth.
In premarket trading, Palantir rose 0.57% to $28.38, according to <a href="https://benzinga.grsm.io/register174">Benzinga Pro data. </a>The stock is up over 64% year-to-date.
See Also: <a href="https://www.benzinga.com/money/best-artificial-intelligence-stocks">Best Artificial Intelligence Stocks</a>
Photo via Shutterstock

Analyst Color

Equities

Price Target

Reiteration

Analyst Ratings

Trading Ideas

PLTR

Palantir Stock Up Over 60% This Year, But Analyst Says The Story Remains 'Very Undervalued And Misunderstood By The Street'

Syntec Optics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTX#NASDAQ">OPTX</a>), a leading provider of scientific, technical instruments, aerospace, and defense optics, announced today that it has secured over $2.2 million in orders for its ultra-high-precision space optics. The company will utilize its newly developed dedicated production cell to scale production for deliveries scheduled for the third quarter of 2024.

OPTX

Syntec Optics Secures $2.2M In New Orders For Space Optics

Armlogi Holding Corp. ("Armlogi" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOC#NASDAQ">BTOC</a>), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today announced the substantial expansion of its trucking department through increased staffing, enhanced equipment, and extended services. This strategic expansion aims to double the trucking volume and extend specialized services to major clients, including Amazon, to address the growing demands of the e-sports logistics industry and other key market sectors.
Since 2023, Armlogi has observed significant trends in logistics that prompted a broadening of its service offerings. The Company has increased its port delivery capabilities and enhanced long- and short-distance logistics services to improve delivery timeliness, professionalism, and customization. This response to customer needs has led to doubling its customer base compared to the same period last year, with many new clients being prominent players in the e-sports logistics field.

BTOC

Armlogi Expands Trucking Operations To Meet Growing Customer Demand

JP Morgan analyst Rachel Vatnsdal downgrades 10x Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) from Overweight to Neutral and lowers the price target from $40 to $20.

Downgrades

JP Morgan Downgrades 10x Genomics to Neutral, Lowers Price Target to $20

RBC Capital analyst Jon Arfstrom maintains Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) with a Outperform and raises the price target from $46 to $49.

ALLY

RBC Capital Maintains Outperform on Ally Financial, Raises Price Target to $49

Bell to expand use of the ServiceNow platform to augment tech services portfolio for Bell Business Markets enterprise customers as well as transform its network and IT infrastructure
Now Platform to streamline business-critical areas for Bell, including Network, Customer, Field Service Operations, and Corporate Services
MONTRÉAL&nbsp;and&nbsp;SANTA&nbsp;CLARA, Calif., July 18, 2024 /CNW/ -&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4214431-1&amp;h=517228798&amp;u=https%3A%2F%2Fwww.bell.ca%2F&amp;a=Bell+Canada">Bell Canada</a>, Canada's communications, tech services and digital media leader, and&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4214431-1&amp;h=3119280436&amp;u=http%3A%2F%2Fwww.servicenow.com%2F&amp;a=ServiceNow">ServiceNow</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>), the AI platform for business transformation, today announced&nbsp;a multi-year strategic agreement to accelerate Bell's transformation to meet the growing customer demand for tech services and digital media. The renewed commitment makes Bell one of ServiceNow's largest communications customers with a first of its kind collaboration in Canada.&nbsp;Bell will expand its use of the ServiceNow platform, supporting its own digital transformation while continuing to offer ServiceNow implementation expertise to support the digital transformation of its Bell Business Markets customers.

Bell Canada And ServiceNow Announce Expanded Multi-Year Strategic Agreement, Supporting Its Own Digital Transformation While Continuing To Offer ServiceNow Implementation Expertise To Support The Digital Transformation Of Its Bell Business Markets Customers

Evolv Becomes A Part of Guest Experience Improvements at Windy City Landmark
Evolv Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>), a leading security technology company pioneering AI-based screening to create safer experiences, today announced its partnership with 360 CHICAGO, the observation deck and immersive experience on the 94th floor of 875 N Michigan Avenue, formerly the John Hancock Center in Chicago, Illinois.
360 CHICAGO uses an <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolvtechnology.com%2Fproducts%2Fevolv-express&amp;esheet=54095938&amp;newsitemid=20240718546656&amp;lan=en-US&amp;anchor=Evolv+Express&amp;index=1&amp;md5=25335a8bd966037216ae9d4723b8ee0d">Evolv Express</a>&#xAE; system to screen guests before they take the elevator up to the experience, which includes the TILT thrill ride and CloudBar, a cocktail lounge with panoramic views of the city. The system was installed in August 2023 after venue officials saw Evolv screening fans attending a local sporting event. 360 CHICAGO used to conduct manual bag checks at entry. When it recently underwent renovations, it included Evolv in a number of upgrades.

EVLV

Evolv Technology Elevates 360 CHICAGO Experience, Evolv Becomes A Part Of Guest Experience Improvements At Windy City Landmark

Truist Securities analyst Barry Jonas maintains Light &amp; Wonder (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNW#NASDAQ">LNW</a>) with a Buy and raises the price target from $115 to $120.

Truist Securities Maintains Buy on Light & Wonder, Raises Price Target to $120

Macro Economic Events

Macro Notification

Economics

General

ECB Leaves Rates Unchanged

Pure Biologics' exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.twistbioscience.com%2F&amp;esheet=54096019&amp;newsitemid=20240718647518&amp;lan=en-US&amp;anchor=Twist+Bioscience+Corporation&amp;index=1&amp;md5=a8252773dd773dfe5623b7bd1012baf5">Twist Bioscience Corporation</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the first patient has been dosed in Pure Biologics' exploratory Phase 0 clinical study of PBA-0405. PBA-0405 is a fully human IgG1 antibody that was discovered using Twist Biopharma Solutions' synthetic antibody phage display libraries. Twist Biopharma Solutions, a division of Twist Bioscience, provides an integrated offering of in vitro, in vivo, and in silico tools for antibody discovery research. This exploratory study is designed to provide early insights into the biological effects of PBA-0405 within the tumor environment.

Biotech

TWST

Twist Bioscience Announces Clinical Progression Of Pure Biologics' Antibody Candidate Discovered Using Twist's Antibody Libraries

TD Cowen analyst Gregory Williams maintains Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) with a Buy and raises the price target from $124 to $127.

TD Cowen Maintains Buy on Crown Castle, Raises Price Target to $127

Truist Securities analyst Barry Jonas maintains Golden Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDEN#NASDAQ">GDEN</a>) with a Buy and lowers the price target from $43 to $40.

GDEN

Truist Securities Maintains Buy on Golden Entertainment, Lowers Price Target to $40

Dr. Reddy's Signs Non-Exclusive Patent Licensing Agreement With Takeda To Commercialize Vonoprazan In India

NKGen will present data on SNK01&#39;s ability to reduce &alpha;-synuclein in Alzheimer&#39;s patients, which is significant given that &alpha;-synuclein has been shown to correlate with worse cognitive function in Alzheimer&#39;s disease.

Health Care

NKGN

NKGen Biotech Will Present New Biomarker Data On SNK01 (Autologous Non-genetically Modified Nk Cell Therapy) In Alzheimer's Disease During A Poster Presentation At The Upcoming Alzheimer's Association International Conference From July 28 – August 1

Facebook owner considers multibillion investment in European eyewear group to expand smart glasses partnership
 <a href="https://www.ft.com/content/4da37b6a-b241-4090-9445-467087694ab7" title="https://www.ft.com/content/4da37b6a-b241-4090-9445-467087694ab7">https://www.ft.com/content/4da37b6a-b241-4090-9445-467087694ab7</a>

'Meta explores stake in Ray-Ban maker EssilorLuxottica' - Financial Times

Calidi Biotherapeutics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#NYSE">CLDI</a>), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the issuance of a new patent for the company's SuperNova technology, strengthening its intellectual property portfolio and positioning Calidi to advance its CLD-201 program into the clinic. &nbsp;
The United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,036,278 titled, "Smallpox Vaccine for Cancer Treatment," directed to Calidi's SuperNova platform composed of adipose-derived mesenchymal stem cells loaded with oncolytic vaccinia virus.

CLDI

Calidi Biotherapeutics Receives Issuance Of New U.S. Patent Covering Novel SuperNova Technology Platform

Southern California Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAL#NASDAQ">BCAL</a>), the holding company for Bank of Southern California, N.A., and California BanCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALB#NASDAQ">CALB</a>), the holding company for California Bank of Commerce, announce that at meetings of their respective shareholders held on July 17, 2024, Southern California Bancorp and California BanCorp shareholders approved the merger of California BanCorp with and into Southern California Bancorp, with Southern California Bancorp the surviving corporation pursuant to the Merger Agreement, dated January 30, 2024, by and between Southern California Bancorp and California BanCorp. &nbsp;
Shareholders of Southern California Bancorp also approved a change of the company's name from Southern California Bancorp to California BanCorp and an amendment to Southern California Bancorp's bylaws to change the allowable range of members of the board of directors to seven to 13, from its previous range of six to 11.

BCAL

CALB

Southern California Bancorp And California BanCorp Announce Receipt Of Shareholder Approvals For Merger

JP Morgan analyst Joseph Greff downgrades Melco Resorts and Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLCO#NASDAQ">MLCO</a>) from Overweight to Neutral and lowers the price target from $10 to $7.

Melco Resorts & Entertainment Limited - American Depositary Shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Trident Brands

News

Latest news for Trident Brands (OTC:TDNT) Stock